BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6377685)

  • 1. [Inhibitors of beta-oxidation of fatty acids (review)].
    Kendysh IN
    Vopr Med Khim; 1984; 30(2):18-27. PubMed ID: 6377685
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of beta-oxidation.
    Schulz H
    Prog Clin Biol Res; 1990; 321():153-65. PubMed ID: 2183230
    [No Abstract]   [Full Text] [Related]  

  • 3. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of fatty acid oxidation.
    Schulz H
    Life Sci; 1987 Apr; 40(15):1443-9. PubMed ID: 3550347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of biosynthesis and oxidation of fatty acids and glycerides at the cellular level in mammalian tissues].
    Alimova EK; Astvatsatur'ian AT; Zharov LV
    Vopr Med Khim; 1974; 20(5):451-62. PubMed ID: 4156442
    [No Abstract]   [Full Text] [Related]  

  • 6. Biosynthesis and mitochondrial import of fatty acid oxidation enzymes.
    Mori M; Amaya Y; Arakawa H; Takiguchi M
    Prog Clin Biol Res; 1990; 321():663-72. PubMed ID: 2326321
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
    Reinauer H; Adrian M; Rösen P; Schmitz FJ
    J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid and ketone metabolism.
    Bieber LL; Fiol CJ
    Circulation; 1985 Nov; 72(5 Pt 2):IV9-12. PubMed ID: 4053330
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased platelet aggregation and fatty acid oxidation in diabetic rats.
    Iida N; Iida R; Takeyama N; Tanaka T
    Biochem Mol Biol Int; 1993 May; 30(1):177-85. PubMed ID: 8358330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of inhibiting fatty acid oxidation on basal glucose metabolism in Psammomys obesus.
    Barnett M; Habito R; Cameron-Smith D; Yamamoto A; Collier GR
    Horm Metab Res; 1996 Apr; 28(4):165-70. PubMed ID: 8740190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term regulation of carnitine palmitoyltransferase activity in isolated rat hepatocytes.
    Guzmán M; Geelen MJ
    Biochem Biophys Res Commun; 1988 Mar; 151(2):781-7. PubMed ID: 3348811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.
    Hoppel CL
    Fed Proc; 1982 Oct; 41(12):2853-7. PubMed ID: 7128831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon.
    Nosadini R; Ursini F; Tessari P; Giengo A; Gregolin C
    Horm Metab Res; 1979 Dec; 11(12):661-4. PubMed ID: 395060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carnitine and fatty acid oxidation].
    Vasil'eva ED
    Usp Sovrem Biol; 1972; 74(2):198-212. PubMed ID: 4565449
    [No Abstract]   [Full Text] [Related]  

  • 15. Resolution of the subcellular site of very long-chain fatty acid beta-oxidation in human skin fibroblasts using a novel approach.
    Jakobs BS; Wanders RJ
    Prog Clin Biol Res; 1992; 375():231-8. PubMed ID: 1438368
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of mitochondrial carnitine palmitoyl transferase A in vivo with methyl 2-tetradecylglycidate (methyl palmoxirate) and its relationship to ketonemia and glycemia.
    Tutwiler GF; Brentzel HJ; Kiorpes TC
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):288-96. PubMed ID: 3969383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between gluconeogenesis and fatty acid oxidation in isolated sheep hepatocytes.
    Chow JC; Jesse BW
    J Dairy Sci; 1992 Aug; 75(8):2142-8. PubMed ID: 1401366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatic fatty acid oxidation by 5-methoxyindole-2-carboxylic acid.
    Corkey BE; Peterson MJ; Pereira JN; Mayhew DA
    Isr J Med Sci; 1972 Jun; 8(6):855-6. PubMed ID: 5051821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.